Bio-Rad Laboratories Profit Margin

Bio-Rad Laboratories (BIO) currently reports a profit margin of 39.45% as of September 2026. That compares with -28.93% in the prior-year period — up 236.4% year over year. That is above the Healthcare sector average of 19.13%. Use the charts on this page to explore Bio-Rad Laboratories's profit margin history and peer comparisons.

Bio-Rad Laboratories's profit margin increased from -28.93% to 39.45% — a 236.4% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bio-Rad Laboratories's profit margin of 39.45% is higher than the Healthcare sector average of 19.13%. That is roughly 106.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bio-Rad Laboratories's current 39.45% should be judged against Healthcare norms (sector average: 19.13%) and against BIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 39.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Bio-Rad Laboratories, and consider following BIO for alerts when major investors trade the stock.